Emerging technologies for the detection of viral infections.

Peter D Burbelo, Michael J Iadarola, Adrija Chaturvedi
Author Information
  1. Peter D Burbelo: Dental Clinical Research Core, National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD, USA.
  2. Michael J Iadarola: Department of Perioperative Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
  3. Adrija Chaturvedi: Dental Clinical Research Core, National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD, USA.

Abstract

Viruses represent one of the major environmental agents that cause human illness and disease. However, the ability to diagnose viral infections is limited by detection capability and scope. Here we describe several emerging technologies that provide rapid and/or high-quality viral diagnostic information. Two technologies, novel CRISPR-based diagnostics and a portable DNA sequencing instrument, are uniquely suited to increase the number of viral agents analyzed, even in point of care settings. We also discuss a phage-based method for generating comprehensive viral profiles of previous exposure/infection and a fluid-phase immunoassay that yields highly quantitative viral antibody analyses. Future applications of these approaches will accelerate on-site clinical diagnosis of viral infections and provide insights into the role viruses play in complex diseases.

Keywords

References

  1. PLoS One. 2013 Dec 02;8(12):e81635 [PMID: 24312567]
  2. Transl Res. 2015 Feb;165(2):325-35 [PMID: 25241936]
  3. PLoS Pathog. 2009 May;5(5):e1000455 [PMID: 19478873]
  4. Sci Rep. 2017 Jun 19;7(1):3818 [PMID: 28630417]
  5. Nat Rev Microbiol. 2017 Mar;15(3):183-192 [PMID: 28090077]
  6. Blood. 2011 Jun 2;117(22):5835-49 [PMID: 21454450]
  7. Nature. 2016 Oct 13;538(7624):270-273 [PMID: 27669025]
  8. Clin Vaccine Immunol. 2009 May;16(5):621-7 [PMID: 19261774]
  9. mBio. 2014 Feb 25;5(2):e00884-14 [PMID: 24570370]
  10. J Infect Dis. 2010 Jun 15;201(12):1919-22 [PMID: 20443737]
  11. Nature. 2016 Feb 11;530(7589):228-232 [PMID: 26840485]
  12. J Pediatric Infect Dis Soc. 2015 Sep;4(3):e53-7 [PMID: 26407445]
  13. Cell. 2014 Mar 27;157(1):142-50 [PMID: 24679532]
  14. Genome Med. 2016 Apr 01;8(1):32 [PMID: 27037032]
  15. Retrovirology. 2008 Oct 20;5:96 [PMID: 18937847]
  16. Mol Biosyst. 2011 May;7(5):1453-62 [PMID: 21336381]
  17. Emerg Infect Dis. 2018 Feb;24(2):303-310 [PMID: 29350162]
  18. Blood. 2012 May 17;119(20):4645-55 [PMID: 22490332]
  19. Clin Vaccine Immunol. 2014 Sep;21(9):1288-91 [PMID: 24990909]
  20. J Clin Oncol. 2013 Jul 20;31(21):2708-15 [PMID: 23775966]
  21. Clin Vaccine Immunol. 2009 Mar;16(3):366-71 [PMID: 19129469]
  22. Science. 2015 Jun 5;348(6239):aaa0698 [PMID: 26045439]
  23. Clin Infect Dis. 2015 Mar 15;60(6):881-8 [PMID: 25572899]
  24. Oral Oncol. 2015 Jul;51(7):662-7 [PMID: 25957822]
  25. PLoS One. 2011;6(8):e22576 [PMID: 21829634]
  26. Proc Natl Acad Sci U S A. 2015 Dec 22;112(51):E7118-27 [PMID: 26621739]
  27. Nature. 2018 Apr;556(7700):255-258 [PMID: 29618817]
  28. Science. 2018 Apr 27;360(6387):439-444 [PMID: 29449508]
  29. Science. 2018 Apr 27;360(6387):381-382 [PMID: 29700254]
  30. Virology. 2015 May;479-480:194-9 [PMID: 25731958]
  31. J Infect Dis. 2010 Sep 15;202(6):894-8 [PMID: 20684729]
  32. J Clin Virol. 2001 Oct;22(3):305-13 [PMID: 11564596]
  33. Hepatology. 2018 Aug;68(2):435-448 [PMID: 28859226]
  34. Genome Med. 2015 Sep 29;7:99 [PMID: 26416663]
  35. J Virol. 2012 Jun;86(11):6171-8 [PMID: 22491452]
  36. Emerg Infect Dis. 2016 Feb;22(2):331-4 [PMID: 26812583]
  37. J Infect Dis. 2018 Mar 13;217(7):1024-1032 [PMID: 29401308]
  38. Science. 2017 Apr 28;356(6336):438-442 [PMID: 28408723]
  39. N Engl J Med. 1998 Apr 2;338(14):948-54 [PMID: 9521982]
  40. Trends Genet. 2018 Sep;34(9):666-681 [PMID: 29941292]
  41. N Engl J Med. 2008 Mar 6;358(10):991-8 [PMID: 18256387]
  42. Immunity. 2015 May 19;42(5):805-13 [PMID: 25992857]
  43. Clin Infect Dis. 2015 Mar 15;60(6):919-23 [PMID: 25572898]
  44. Cell. 2014 Nov 6;159(4):718-20 [PMID: 25417149]
  45. Virology. 2009 Sep 15;392(1):1-10 [PMID: 19720205]
  46. Science. 2018 Apr 27;360(6387):444-448 [PMID: 29700266]

Grants

  1. Z99 DE999999/Intramural NIH HHS

Word Cloud

Created with Highcharts 10.0.0viralinfectionstechnologiessequencingagentsdetectionprovideDNAdiagnosisVirusesrepresentonemajorenvironmentalcausehumanillnessdiseaseHoweverabilitydiagnoselimitedcapabilityscopedescribeseveralemergingrapidand/orhigh-qualitydiagnosticinformationTwonovelCRISPR-baseddiagnosticsportableinstrumentuniquelysuitedincreasenumberanalyzedevenpointcaresettingsalsodiscussphage-basedmethodgeneratingcomprehensiveprofilespreviousexposure/infectionfluid-phaseimmunoassayyieldshighlyquantitativeantibodyanalysesFutureapplicationsapproacheswillaccelerateon-siteclinicalinsightsrolevirusesplaycomplexdiseasesEmergingCRISPRLuciferaseImmunoprecipitationSystemsVirScanhigh-throughputnanopore

Similar Articles

Cited By (10)